These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 18651534

  • 1. IgA nephropathy: lessons from an animal model, the ddY mouse.
    Tomino Y.
    J Nephrol; 2008; 21(4):463-7. PubMed ID: 18651534
    [Abstract] [Full Text] [Related]

  • 2. Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy.
    Kajiyama T, Suzuki Y, Kihara M, Suzuki H, Horikoshi S, Tomino Y.
    Clin Dev Immunol; 2011; 2011():819646. PubMed ID: 21765852
    [Abstract] [Full Text] [Related]

  • 3.
    Tashakkorinia N, Muco E, Tudor ME.
    ; 2024 01. PubMed ID: 29763174
    [Abstract] [Full Text] [Related]

  • 4. The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology.
    Rops AL, Figdor CG, van der Schaaf A, Tamboer WP, Bakker MA, Berden JH, Dijkman HB, Steenbergen EJ, van der Vlag J, van Spriel AB.
    Am J Pathol; 2010 May; 176(5):2188-97. PubMed ID: 20348240
    [Abstract] [Full Text] [Related]

  • 5. Charting new frontiers in IgA nephropathy: a paradigm shift toward precision medicine and early intervention?
    Selvaskandan H, Barratt J.
    Kidney Int; 2024 Apr; 105(4):659-661. PubMed ID: 38519229
    [Abstract] [Full Text] [Related]

  • 6. Influence of IgA nephropathy on the progression of pulpitis and apical periodontitis in HIGA mice.
    Hayashi R, Yamazaki S, Mutoh N, Hashimoto T, Ohshima H, Tani-Ishii N.
    J Oral Biosci; 2024 Mar; 66(1):98-104. PubMed ID: 37979655
    [Abstract] [Full Text] [Related]

  • 7. Exploring the pathogenesis and treatment of IgA nephropathy based on epigenetics.
    Zhang Y, Yang H, Jiang M, Nie X.
    Epigenomics; 2023 Oct; 15(19):1017-1026. PubMed ID: 37909120
    [Abstract] [Full Text] [Related]

  • 8. B-Cell Epigenetic Modulation of IgA Response by 5-Azacytidine and IgA Nephropathy.
    Yu S, Li X, Wang T, Li J, Li H, Xu Y, Hu Y, Zhu F, Wang J, Wang T, Zhu B, Zhou XJ, Zhang H, Lv J, Barratt J, Zhao B.
    J Am Soc Nephrol; 2024 Aug 13. PubMed ID: 39137052
    [No Abstract] [Full Text] [Related]

  • 9. IgA nephropathy with podocytic infolding glomerulopathy.
    Wang Z, Diao Y, Wang Z, Yang X, Zhen J, Liu G.
    Chronic Dis Transl Med; 2023 Dec 13; 9(4):345-348. PubMed ID: 37915389
    [Abstract] [Full Text] [Related]

  • 10. Sodium excretion per nephron and nighttime hypertension in patients with IgA nephropathy.
    Marumoto H, Tsuboi N, Sasaki T, Okabayashi Y, Haruhara K, Kanzaki G, Koike K, Yokoo T.
    Hypertens Res; 2024 Sep 13; 47(9):2616-2618. PubMed ID: 39014116
    [No Abstract] [Full Text] [Related]

  • 11. Two cases of IgA nephropathy after splenectomy: spleen as a silent culprit in the pathogenesis of IgA nephropathy.
    Dirim AB, Agargun BF, Hurdogan O, Ozluk Y, Safak S, Garayeva N, Esen BA, Besisik SK, Yazici H.
    J Nephrol; 2023 Nov 13; 36(8):2381-2385. PubMed ID: 37665525
    [No Abstract] [Full Text] [Related]

  • 12. Erratum for Cai et al., "Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy".
    Cai F, Zhou C, Jiao N, Liang X, Ye Z, Chen W, Yang Q, Peng H, Tang Y, Niu C, Zhao G, Wang Z, Zhang G, Yu X.
    Microbiol Spectr; 2023 Sep 29; 11(5):e0268623. PubMed ID: 37772813
    [No Abstract] [Full Text] [Related]

  • 13. Learning from deep learning and pathomics.
    Fogo AB.
    Kidney Int; 2023 Dec 29; 104(6):1050-1053. PubMed ID: 37336291
    [No Abstract] [Full Text] [Related]

  • 14. Targeting APRIL in the Treatment of IgA Nephropathy.
    Cheung CK, Barratt J, Carroll K, Lafayette RA, Liew A, Suzuki Y, Tesař V, Trimarchi H, Wong MG, Zhang H, Perkovic V, Rizk DV.
    Clin J Am Soc Nephrol; 2024 Mar 01; 19(3):394-398. PubMed ID: 37801688
    [No Abstract] [Full Text] [Related]

  • 15. Development of Animal Models of Human IgA Nephropathy.
    Suzuki H, Suzuki Y, Novak J, Tomino Y.
    Drug Discov Today Dis Models; 2014 Mar 01; 11():5-11. PubMed ID: 25722731
    [Abstract] [Full Text] [Related]

  • 16. Prospects and perspectives on IgA nephropathy from animal models.
    Emancipator SN.
    Contrib Nephrol; 2011 Mar 01; 169():126-152. PubMed ID: 21252515
    [Abstract] [Full Text] [Related]

  • 17. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.
    Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M, Fasel D, Lata S, Prakash S, Shapiro S, Fischman C, Snyder HJ, Appel G, Izzi C, Viola BF, Dallera N, Del Vecchio L, Barlassina C, Salvi E, Bertinetto FE, Amoroso A, Savoldi S, Rocchietti M, Amore A, Peruzzi L, Coppo R, Salvadori M, Ravani P, Magistroni R, Ghiggeri GM, Caridi G, Bodria M, Lugani F, Allegri L, Delsante M, Maiorana M, Magnano A, Frasca G, Boer E, Boscutti G, Ponticelli C, Mignani R, Marcantoni C, Di Landro D, Santoro D, Pani A, Polci R, Feriozzi S, Chicca S, Galliani M, Gigante M, Gesualdo L, Zamboli P, Battaglia GG, Garozzo M, Maixnerová D, Tesar V, Eitner F, Rauen T, Floege J, Kovacs T, Nagy J, Mucha K, Pączek L, Zaniew M, Mizerska-Wasiak M, Roszkowska-Blaim M, Pawlaczyk K, Gale D, Barratt J, Thibaudin L, Berthoux F, Canaud G, Boland A, Metzger M, Panzer U, Suzuki H, Goto S, Narita I, Caliskan Y, Xie J, Hou P, Chen N, Zhang H, Wyatt RJ, Novak J, Julian BA, Feehally J, Stengel B, Cusi D, Lifton RP, Gharavi AG.
    Nat Genet; 2014 Nov 01; 46(11):1187-96. PubMed ID: 25305756
    [Abstract] [Full Text] [Related]

  • 18. Development of a model of early-onset IgA nephropathy.
    Okazaki K, Suzuki Y, Otsuji M, Suzuki H, Kihara M, Kajiyama T, Hashimoto A, Nishimura H, Brown R, Hall S, Novak J, Izui S, Hirose S, Tomino Y.
    J Am Soc Nephrol; 2012 Aug 01; 23(8):1364-74. PubMed ID: 22797187
    [Abstract] [Full Text] [Related]

  • 19. Tonsillar CD4+CD25+ regulatory T cells from IgA nephropathy patients have decreased immunosuppressive activity in experimental IgA nephropathy rats.
    Huang H, Peng Y, Long XD, Liu Z, Wen X, Jia M, Liang Y, Huang A.
    Am J Nephrol; 2013 Aug 01; 37(5):472-80. PubMed ID: 23635548
    [Abstract] [Full Text] [Related]

  • 20. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.
    Hashimoto A, Suzuki Y, Suzuki H, Ohsawa I, Brown R, Hall S, Tanaka Y, Novak J, Ohi H, Tomino Y.
    Am J Pathol; 2012 Oct 01; 181(4):1338-47. PubMed ID: 22871574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.